Abbati Francesca, Altimari Annalisa, Corti Barbara, Dika Emi, Sperandi Francesca, Melotti Barbara
Department of Medical Oncology IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy.
Laboratory of Oncologic Molecular Pathology IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna Italy.
Clin Case Rep. 2021 Mar 7;9(4):2200-2204. doi: 10.1002/ccr3.3982. eCollection 2021 Apr.
We report the case of a young woman who developed metastatic melanoma in the inguinal nodal region, which acquired chondrosarcomatous differentiation and preserved the BRAF mutation found in the primary tumor. The patient was treated with a BRAF/MEK inhibitor combination therapy (dabrafenib/trametinib), which was demonstrated to be effective and well-tolerated.
我们报告了一名年轻女性的病例,该患者在腹股沟淋巴结区域发生了转移性黑色素瘤,该肿瘤获得了软骨肉瘤样分化,并保留了原发肿瘤中发现的BRAF突变。患者接受了BRAF/MEK抑制剂联合治疗(达拉非尼/曲美替尼),结果显示该治疗有效且耐受性良好。